Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Tax drag in index funds describes taxes paid on gains within the fund that reduce overall returns. This piece explains what causes drag and how to minimize it.
15,832 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
New student loan rules take effect on July 1, redefining borrowing limits and repayment options for millions of borro...
Fiverr International sits near a 52-week low, inviting questions about its future. This article breaks down the busin...
Venice AI closes a $65 million Series A led by Dragonfly at a $1 billion valuation, funding growth with equity. The m...
When headlines shout about dream finders homes struggles, investors should look past the noise and examine the fundam...
Ripple aims to shift a multi-trillion-dollar post-trade flow onto the XRP Ledger, a move that could redefine XRP liqu...
Trump granted clemency to 11 people on a Friday ahead of July 4, spotlighting emissions-related cases and a partner o...
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...
AMD tracks a rapid data-center rebound with 57% YoY growth, challenging Nvidia as hyperscalers back MI450. Investors ...
The AI wave is accelerating, and savvy investors are looking for blue-chip names with durable AI catalysts. This guid...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
Roku and Sirius XM sit at opposite ends of the media stock spectrum: one is a fast-growing platform, the other a stea...